# Keros Therapeutics Inc. (KROS) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $68M |
| 2024 | -$211M |
| 2023 | -$170M |
| 2022 | -$115M |
| 2021 | -$56M |
| 2020 | -$47M |
| 2019 | -$11M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$26M |
| 2025-09-30 | -$15M |
| 2025-06-30 | -$40M |
| 2025-03-31 | $152M |
| 2024-09-30 | -$59M |
| 2024-06-30 | -$50M |
| 2024-03-31 | -$48M |
| 2023-09-30 | -$43M |
| 2023-06-30 | -$41M |
| 2023-03-31 | -$39M |
| 2022-09-30 | -$28M |
| 2022-06-30 | -$31M |
| 2021-09-30 | -$20M |
| 2021-06-30 | -$16M |
| 2020-09-30 | -$12M |
| 2020-06-30 | -$11M |
| 2020-03-31 | -$11M |
| 2019-09-30 | -$2M |
| 2019-06-30 | -$3M |
| 2019-03-31 | -$3M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/KROS/operating-income)